These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
384 related items for PubMed ID: 17286792
1. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups. Li D, Zhang GL, Lou YQ, Li Q, Wang X, Bu XY. J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792 [Abstract] [Full Text] [Related]
2. CYP3A5*3 and MDR-1 C3435T single nucleotide polymorphisms in six Chinese ethnic groups. Lai Y, Zhang J, Wang YX, Wang XD, Li JL, Wang YH, Zeng YJ, Huang M. Pharmazie; 2011 Feb; 66(2):136-40. PubMed ID: 21434577 [Abstract] [Full Text] [Related]
3. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations. Wang SM, Zhu AP, Li D, Wang Z, Zhang P, Zhang GL. J Hum Genet; 2009 Jun; 54(6):372-5. PubMed ID: 19444287 [Abstract] [Full Text] [Related]
4. Functional allele and genotype frequencies of CYP1A2, CYP2B6 and iNOS among mainland Chinese Tibetan, Mongolian, Uygur and Han populations. Qi GZ, Zhang ZY, Wang X, Yin SJ, Lou YQ, Zhang GL. J Clin Pharm Ther; 2016 Feb; 41(1):84-91. PubMed ID: 26763760 [Abstract] [Full Text] [Related]
5. Influence of CYP3A5 and MDR1 genetic polymorphisms on urinary 6 beta-hydroxycortisol/cortisol ratio after grapefruit juice intake in healthy Chinese. Li D, Abudula A, Abulahake M, Zhu AP, Lou YQ, Zhang GL. J Clin Pharmacol; 2010 Jul; 50(7):775-84. PubMed ID: 20160155 [Abstract] [Full Text] [Related]
6. MDR1 genotypes do not influence the absorption of a single oral dose of 600 mg valacyclovir in healthy Chinese Han ethnic males. Zhang Y, Jiang XH, Hu YQ, Li ZR, Su L, Wang ZG, Ma G. Br J Clin Pharmacol; 2008 Aug; 66(2):247-54. PubMed ID: 18460034 [Abstract] [Full Text] [Related]
7. CYP3A5 3, CYP3A4 1B and MDR1 C3435T genotype distributions in Ecuadorians. Sinués B, Vicente J, Fanlo A, Mayayo-Sinués E, González-Andrade F, Sánchez-Q D, Martínez-Jarreta B. Dis Markers; 2008 Aug; 24(6):325-31. PubMed ID: 18688081 [Abstract] [Full Text] [Related]
9. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Hu YF, Qiu W, Liu ZQ, Zhu LJ, Liu ZQ, Tu JH, Wang D, Li Z, He J, Zhong GP, Zhou G, Zhou HH. Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1093-8. PubMed ID: 17042920 [Abstract] [Full Text] [Related]
10. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers. Xu P, Jiang ZP, Zhang BK, Tu JY, Li HD. Pharmacology; 2008 Nov; 82(3):221-7. PubMed ID: 18810246 [Abstract] [Full Text] [Related]
11. Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients. Rong G, Jing L, Deng-Qing L, Hong-Shan Z, Shai-Hong Z, Xin-Min N. Transplant Proc; 2010 Nov; 42(9):3455-8. PubMed ID: 21094796 [Abstract] [Full Text] [Related]
12. Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients. Wu P, Ni X, Wang M, Xu X, Luo G, Jiang Y. Ann Transplant; 2011 Nov; 16(1):54-60. PubMed ID: 21436775 [Abstract] [Full Text] [Related]
13. Correlation between MDR1 methylation status in the promoter region and MDR1 genetic polymorphism in 194 healthy Chinese Han subjects. Jiang ZP, Xu P, Liu RR, Li HD, Wang GP, Zhao XL, Chen FP. Pharmacogenomics; 2008 Dec; 9(12):1801-8. PubMed ID: 19072639 [Abstract] [Full Text] [Related]
14. Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations. Gervasini G, Vizcaino S, Gasiba C, Carrillo JA, Benitez J. Ther Drug Monit; 2005 Dec; 27(6):819-21. PubMed ID: 16306861 [Abstract] [Full Text] [Related]
15. Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients. Li D, Lu W, Zhu JY, Gao J, Lou YQ, Zhang GL. J Clin Pharm Ther; 2007 Oct; 32(5):505-15. PubMed ID: 17875118 [Abstract] [Full Text] [Related]
16. Frequencies of CYP3A5 genotypes and haplotypes in a Korean population. Park SY, Kang YS, Jeong MS, Yoon HK, Han KO. J Clin Pharm Ther; 2008 Feb; 33(1):61-5. PubMed ID: 18211618 [Abstract] [Full Text] [Related]
17. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. Yin SJ, Ni YB, Wang SM, Wang X, Lou YQ, Zhang GL. J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948 [Abstract] [Full Text] [Related]
18. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent. Rodrigues AC, Rebecchi IM, Bertolami MC, Faludi AA, Hirata MH, Hirata RD. Braz J Med Biol Res; 2005 Sep; 38(9):1389-97. PubMed ID: 16138223 [Abstract] [Full Text] [Related]
19. Influence of the CYP3A5 and MDR1 genetic polymorphisms on the pharmacokinetics of tacrolimus in healthy Korean subjects. Choi JH, Lee YJ, Jang SB, Lee JE, Kim KH, Park K. Br J Clin Pharmacol; 2007 Aug; 64(2):185-91. PubMed ID: 17391324 [Abstract] [Full Text] [Related]
20. [CYP2D6 genotypes and phenotypes in Chinese Han, Uygur and Kazakh populations]. Li GC, Yang J, Zhou T, Chen ZG, Chen W. Yao Xue Xue Bao; 2011 Feb; 46(2):238-42. PubMed ID: 21542297 [Abstract] [Full Text] [Related] Page: [Next] [New Search]